510(k) · Cleared

Cleared

HBA1C Control, Level 1 and Level 2

K131999510(k) TraditionalCleared Jul 26, 201328-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Randox Laboratories, Ltd. · JJX Single (Specified) Analyte Controls (Assayed And Unassayed)

Cleared on Jul 26, 2013 as substantially equivalent to K103099 (Roche Diagnostics, 2010) after a 28-day review. Its family tree reaches back 1 generation to 2010.

Decided: Jul 26, 2013
Review: 28 days
Class: Class I
Product code: JJX
Recalls: None
Predicates: 1

Its longest line of descent runs back 1 generation to K103099 (2010). No later device cites it as a predicate yet.

By dateBy generation

Root · 1 generation backK103099 Precicontrol HBA1C Norm; Precicontrol HBA1C PathRoche Diagnostics · 2010
This deviceK131999 HBA1C Control, Level 1 and Level 2Randox Laboratories, Ltd. · 2013

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−1	K103099	Precicontrol HBA1C Norm; Precicontrol HBA1C Path	Roche Diagnostics	2010	—
0 (this device)	K131999	HBA1C Control, Level 1 and Level 2	Randox Laboratories, Ltd.	2013	—

FIG. 1 — Lineage of K131999, 2010–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Candidate predicates for a device like this, rankedin the report
Recall history across each candidate’s familyin the report

Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K103099	Precicontrol HBA1C Norm; Precicontrol HBA1C Path Summary page 2 …== 4. PREDICATE DEVICE PROPRIETARY NAMES AND 510 (k) NUMBERS Predicate Device Proprietary Name: Roche PreciControl HbAlc norm and PreciControl HbAlc path 510 (k)Number: K1 03099 5. INTENDED USE The HbAlc Controls Level 1 and 2 are intended for in vitro diagnostic use as quality control material for use t…	Roche Diagnostics	2010	—

Also cleared against K103099: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

Its one ancestor has no recall.
1 other device also cites its predicate K103099.

How does its category compare?

All JJX devices

JJX Single (Specified) Analyte Controls (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · JJX

2in 2017

2007high 24 (2010) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJX

31in 2016

2007high 80 (2009) · low 30 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJX

1in 2021

2007high 3 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJX

22in 2025

2007high 82 (2019) · low 0 (2008)2025

MAUDE reports naming product code JJX, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	6	53	3	2
2008	8	52	3	0
2009	17	80	0	1
2010	24	80	3	6
2011	19	62	2	62
2012	15	40	0	32
2013	19	37	0	51
2014	22	30	1	48
2015	11	65	1	67
2016	6	31	2	37
2017	2	—	0	19
2018	0	—	2	35
2019	0	—	0	82
2020	0	—	0	77
2021	0	—	1	43
2022	0	—	0	24
2023	0	—	0	22
2024	0	—	0	30
2025	0	—	0	22
2026	0	—	0	—

What is it indicated for?

The HbAlc Controls 'Level I and 2 are intended for in vitro diagnostic use as quality control material for use to verify the performance of laboratory testing procedures of HbAlc on clinical chemistry systems.

This in vitro diagnostic device is intended for prescription use only.

Indications for use as stated in the FDA summary.

https://510kreport.com/device/K131999 · printed Nov 4, 2026

Cite this page

510(k) Report. “K131999: HBA1C Control, Level 1 and Level 2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K131999

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026